150 related articles for article (PubMed ID: 8747108)
1. Escherichia coli verotoxin binding to human paediatric glomerular mesangial cells.
Robinson LA; Hurley RM; Lingwood C; Matsell DG
Pediatr Nephrol; 1995 Dec; 9(6):700-4. PubMed ID: 8747108
[TBL] [Abstract][Full Text] [Related]
2. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms.
Van Setten PA; van Hinsbergh VW; Van den Heuvel LP; van der Velden TJ; van de Kar NC; Krebbers RJ; Karmali MA; Monnens LA
J Am Soc Nephrol; 1997 Dec; 8(12):1877-88. PubMed ID: 9402090
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators.
Rowe PC; Orrbine E; Lior H; Wells GA; McLaine PN
Epidemiol Infect; 1993 Feb; 110(1):1-7. PubMed ID: 8432313
[TBL] [Abstract][Full Text] [Related]
4. Apparent cooperativity in multivalent verotoxin-globotriaosyl ceramide binding: kinetic and saturation binding studies with [(125)I]verotoxin.
Peter MG; Lingwood CA
Biochim Biophys Acta; 2000 Jun; 1501(2-3):116-24. PubMed ID: 10838185
[TBL] [Abstract][Full Text] [Related]
5. Shiga toxin 1 elicits diverse biologic responses in mesangial cells.
Simon M; Cleary TG; Hernandez JD; Abboud HE
Kidney Int; 1998 Oct; 54(4):1117-27. PubMed ID: 9767527
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor and interleukin 1 induce expression of the glycolipid verotoxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome.
Van de Kar NC; Monnens LA; Van Hinsbergh VW
Behring Inst Mitt; 1993 Aug; (92):202-9. PubMed ID: 8250811
[TBL] [Abstract][Full Text] [Related]
7. Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome.
te Loo DM; Monnens LA; van Der Velden TJ; Vermeer MA; Preyers F; Demacker PN; van Den Heuvel LP; van Hinsbergh VW
Blood; 2000 Jun; 95(11):3396-402. PubMed ID: 10828021
[TBL] [Abstract][Full Text] [Related]
8. Role of verotoxin receptors in pathogenesis.
Lingwood CA
Trends Microbiol; 1996 Apr; 4(4):147-53. PubMed ID: 8728608
[TBL] [Abstract][Full Text] [Related]
9. Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and a monoclonal antibody.
Chark D; Nutikka A; Trusevych N; Kuzmina J; Lingwood C
Eur J Biochem; 2004 Jan; 271(2):405-17. PubMed ID: 14717708
[TBL] [Abstract][Full Text] [Related]
10. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli.
Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM
Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effects of verocytotoxin-1 on primary human renal cell cultures.
Williams JM; Boyd B; Nutikka A; Lingwood CA; Barnett Foster DE; Milford DV; Taylor CM
Toxicol Lett; 1999 Mar; 105(1):47-57. PubMed ID: 10092056
[TBL] [Abstract][Full Text] [Related]
12. Impairment by verotoxin of tubular function contributes to the renal damage seen in haemolytic uraemic syndrome.
Takeda T; Dohi S; Igarashi T; Yamanaka T; Yoshiya K; Kobayashi N
J Infect; 1993 Nov; 27(3):339-41. PubMed ID: 8308331
[No Abstract] [Full Text] [Related]
13. Haemolytic uraemic syndrome associated with faecal cytotoxin and verotoxin neutralizing antibodies.
Novillo AA; Voyer LE; Cravioto R; Freire MC; Castaño G; Wainstein R; Binztein N
Pediatr Nephrol; 1988 Jul; 2(3):288-90. PubMed ID: 3153027
[TBL] [Abstract][Full Text] [Related]
14. The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study.
Bitzan M; Ludwig K; Klemt M; König H; Büren J; Müller-Wiefel DE
Epidemiol Infect; 1993 Apr; 110(2):183-96. PubMed ID: 8472763
[TBL] [Abstract][Full Text] [Related]
15. Association of verotoxin-producing E. coli and verotoxin with hemolytic uremic syndrome.
Arbus GS
Kidney Int Suppl; 1997 Mar; 58():S91-6. PubMed ID: 9067954
[TBL] [Abstract][Full Text] [Related]
16. Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells.
Louise CB; Obrig TG
J Infect Dis; 1995 Nov; 172(5):1397-401. PubMed ID: 7594687
[TBL] [Abstract][Full Text] [Related]
17. Shiga/verocytotoxins and Shiga/verotoxigenic Escherichia coli in animals.
Mainil J
Vet Res; 1999; 30(2-3):235-57. PubMed ID: 10367357
[TBL] [Abstract][Full Text] [Related]
18. Translocation of verotoxin-1 across T84 monolayers: mechanism of bacterial toxin penetration of epithelium.
Philpott DJ; Ackerley CA; Kiliaan AJ; Karmali MA; Perdue MH; Sherman PM
Am J Physiol; 1997 Dec; 273(6):G1349-58. PubMed ID: 9435561
[TBL] [Abstract][Full Text] [Related]
19. Studies on binding and mitogenic effect of insulin and insulin-like growth factor I in glomerular mesangial cells.
Conti FG; Striker LJ; Lesniak MA; MacKay K; Roth J; Striker GE
Endocrinology; 1988 Jun; 122(6):2788-95. PubMed ID: 2967178
[TBL] [Abstract][Full Text] [Related]
20. Verotoxin-binding in human renal sections.
Lingwood CA
Nephron; 1994; 66(1):21-8. PubMed ID: 8107950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
